Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000102909-25-000314·VANGUARD GROUP INC
Schedule 13G ownership disclosure
Ventyx Biosciences Inc
Common Stock · CUSIP: 92332V107
Event date: 2025-09-30
- Filing-level shares
- 3,769,997
- Percent of class
- 5.28%
- The Vanguard Group
Shares: 3,769,997 · Class: 5.28%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-25-000314
- Form type
- SCHEDULE 13G
- Filer
- VANGUARD GROUP INC
- CIK
- CIK 102909
- Filed
- Oct 31, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership